These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
3. Characterization of cancer stem cells from different grades of human colorectal cancer. Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615 [TBL] [Abstract][Full Text] [Related]
4. Subpopulation of colorectal adenocarcinoma cells co-expressing CD133 and cancer stem cells markers of other tumors. Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Frank GA; Yarygin KN Bull Exp Biol Med; 2012 Apr; 152(6):739-42. PubMed ID: 22803178 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment. Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394 [TBL] [Abstract][Full Text] [Related]
6. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. Choi D; Lee HW; Hur KY; Kim JJ; Park GS; Jang SH; Song YS; Jang KS; Paik SS World J Gastroenterol; 2009 May; 15(18):2258-64. PubMed ID: 19437567 [TBL] [Abstract][Full Text] [Related]
8. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note. James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706 [TBL] [Abstract][Full Text] [Related]
9. Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer. Fedyanin M; Anna P; Elizaveta P; Sergei T Curr Stem Cell Res Ther; 2017; 12(1):19-30. PubMed ID: 27593447 [TBL] [Abstract][Full Text] [Related]
10. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells. Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842 [TBL] [Abstract][Full Text] [Related]
11. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178 [TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394 [TBL] [Abstract][Full Text] [Related]
13. CD133+ human colorectal adenocarcinoma cells are resistant to staining with fluorescent dyes used for analysis of ABC transporter activities. Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Frank GA; Yarygin KN Bull Exp Biol Med; 2014 Nov; 158(1):80-3. PubMed ID: 25403403 [TBL] [Abstract][Full Text] [Related]
14. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Wei X; Dombkowski D; Meirelles K; Pieretti-Vanmarcke R; Szotek PP; Chang HL; Preffer FI; Mueller PR; Teixeira J; MacLaughlin DT; Donahoe PK Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18874-9. PubMed ID: 20952655 [TBL] [Abstract][Full Text] [Related]
15. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Ma YC; Yang JY; Yan LN Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672 [TBL] [Abstract][Full Text] [Related]
16. Expression analysis of putative stem cell markers in human benign and malignant prostate. Ugolkov AV; Eisengart LJ; Luan C; Yang XJ Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131 [TBL] [Abstract][Full Text] [Related]